| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.02. | Lipigon Pharmaceuticals AB receives observation status | 490 | GlobeNewswire | On February 16, 2026, Lipigon Pharmaceuticals AB (the "Company") disclosed a press release providing, inter alia, an update regarding the Company's drug candidate Lipisense. The press release also... ► Artikel lesen | |
| LIPIGON PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 14.10.25 | Lipigon Pharmaceuticals AB: Lipigon Pharmaceuticals reports last patient visit in the three-month follow-up of its Phase II clinical study with Lipisense | 180 | GlobeNewswire (Europe) | Lipigon Pharmaceuticals AB (publ) today announced that the last patient in the company's Phase II clinical study of Lipisense® has completed the three-month follow-up. The study includes a total of... ► Artikel lesen | |
| 06.07.25 | Lipigon Pharmaceuticals AB: Lipigon Pharmaceuticals Enrolls Last Patient in Phase II Study with Lipisense | 307 | GlobeNewswire (Europe) | This press release is an English translation of the Swedish press release published by Lipigon Pharmaceuticals AB on 2025-06-23.
Lipigon Pharmaceuticals AB announced today that the last patient has... ► Artikel lesen | |
| 30.04.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.04.2025 | 1.006 | Xetra Newsboard | Das Instrument 8GC JE00B4T3BW64 GLENCORE PLC DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 30.04.2025 und ex Kapitalmassnahme am 02.05.2025 The instrument 8GC JE00B4T3BW64 GLENCORE PLC DL -... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KHIRON LIFE SCIENCES | 0,029 | -100,00 % | Khiron Life Sciences Corp: Khiron Life Sciences warrants to expire Nov. 26 | ||
| CHRISTINA LAKE CANNABIS | 0,014 | +50,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,005 | +12,50 % | Psyched Wellness Ltd.: Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director | Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc. Provides Corporate Update | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Update Regarding Listing Status | Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,031 | -6,06 % | BetterLife Pharma Inc. - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,037 | -11,90 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue | FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,017 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Launches NCAA Division I Athlete Platform Through Multi-Sport NIL Partnership with Virginia Military Institute | Burlington, Ontario--(Newsfile Corp. - April 9, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a developer of advanced proprietary amino... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,051 | +10,99 % | Addex Therapeutics: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment | Data published in Molecular Psychiatry
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland, February 3, 2026
-
Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,011 | -8,33 % | ARGENT BIOPHARMA LIMITED: Completion of CannPal Asset Acquisition and Neuvis Option | ||
| CANNABIST COMPANY | 0,025 | -100,00 % | Cannabist Co Holdings Inc. - 8-K, Current Report | ||
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results | NEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| CENTR BRANDS | 0,001 | 0,00 % | Centr Brands Corp (2): Centr Brands arranges $50,000 debenture financing | ||
| RESTART LIFE SCIENCES | 0,051 | 0,00 % | Restart Life Sciences Corp.: Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth | Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide investors... ► Artikel lesen | |
| AYR WELLNESS | 0,078 | -100,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |